A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

计划入组 40 人 · 首次发布于 2012 年 5 月 7 日

A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery

计划入组 60 人 · 首次发布于 2009 年 1 月 7 日

A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair

计划入组 124 人 · 首次发布于 2009 年 9 月 10 日

28A32 humanized antibodies(Akzo Nobel NV)

SARS-CoV-2 VLP Vaccine(Nobel Pharmaceuticals)

Norbert Hermanns

Germany

Naser Morina

Switzerland

Jens Faber

Germany

Venture Medical Leads €6 Million Investment in Cold Plasma Wound Therapy Developer Plasmacure

MRD Status and Remission Number Impact HSCT Outcomes in AML

MicroRNA Therapeutics Poised for Revival After Nobel Recognition